COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE

NIH RePORTER · NIH · N01 · $9,112,616 · view on reporter.nih.gov ↗

Abstract

To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge influenza vaccine platforms and approaches.

Key facts

NIH application ID
10551180
Project number
75N93019C00053-P00010-9999-1
Recipient
DUKE UNIVERSITY
Principal Investigator
MATTHEW JOHNSON
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$9,112,616
Award type
—
Project period
2019-08-26 → 2025-02-13